In India, Keytruda is approved by the Drug Controller General of India (DCGI) for multiple cancer types. As of recent approvals, it covers 14 indications across eight tumour types.
17h
Keytruda: All about the immunotherapy drug that is being used to treat different types of cancers
Keytruda's first approval by US FDA came in the year 2014 for advanced skin cancer. Now, the immunotherapy drug is being used ...
Boehringer Ingelheim to evaluate combination of DLL3-targeting T-cell engager plus PD-L1/VEGF-A bispecific antibody in small cell lung cancer: Ingelheim, Germany Saturday, April 1 ...
With strong earnings growth and an expanding customer base, it's positioned to feed the rampant demand for Artificial ...
Researchers found that strong interactions between immune receptors promote antidrug antibody production, increasing the risk ...
Nanjing Leads Biolabs Co., Ltd. ("Leads Biolabs" or the "Company," Stock Code: 9887.HK) announced that its proprietary PD-L1/4-1BB bispecific antibody ...
Boehringer Ingelheim today announced a clinical trial collaboration with BioNTech to evaluate a novel immuno--oncology combination in extensive--stage small cell lung cancer (ES-SCLC), one of the most ...
Antibody therapeutics are laboratory-made proteins designed to work like the body's natural antibodies. They are widely used to treat diseases such as ...
Successful transformation to global biotech platform with two mid-stage potential best-in-class/first-in-class programs, givastomig and VIS-101, with compelling proof-of-concept dataGivastomig, a pote ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results